Back to Search
Start Over
How Does Mild Asthma Differ Phenotypically from Difficult-to-Treat Asthma?
- Source :
-
Journal of asthma and allergy [J Asthma Allergy] 2023 Dec 19; Vol. 16, pp. 1333-1345. Date of Electronic Publication: 2023 Dec 19 (Print Publication: 2023). - Publication Year :
- 2023
-
Abstract
- Background: Despite most of the asthma population having mild disease, the mild asthma phenotype is poorly understood. Here, we aim to address this gap in knowledge by extensively characterising the mild asthma phenotype and comparing this with difficult-to-treat asthma.<br />Methods: We assessed two real-world adult cohorts from the South of England using an identical methodology: the Wessex AsThma CoHort of difficult asthma (WATCH) (n=498) and a mild asthma cohort from the comparator arm of the Epigenetics Of Severe Asthma (EOSA) study (n=67). Data acquisition included detailed clinical, health and disease-related questionnaires, anthropometry, allergy and lung function testing, plus biological samples (blood and sputum) in a subset.<br />Results: Mild asthma is predominantly early-onset and is associated with type-2 (T2) inflammation (atopy, raised fractional exhaled nitric oxide (FeNO), blood/sputum eosinophilia) plus preserved lung function. A high prevalence of comorbidities and multimorbidity was observed in mild asthma, particularly depression (58.2%) and anxiety (56.7%). In comparison to difficult asthma, mild disease showed similar female predominance (>60%), T2-high inflammation and atopy prevalence, but lower peripheral blood/airway neutrophil counts and preserved lung function. Mild asthma was also associated with a greater prevalence of current smokers (20.9%). A multi-component T2-high inflammatory measure was comparable between the cohorts; T2-high status 88.1% in mild asthma and 93.5% in difficult asthma.<br />Conclusion: Phenotypic characterisation of mild asthma identified early-onset disease with high prevalence of current smokers, T2-high inflammation and significant multimorbidity burden. Early comprehensive assessment of mild asthma patients could help prevent potential later progression to more complex severe disease.<br />Competing Interests: The authors, JN, HM, FM, JB, MAK, CB, HMH, PD, RD, GS, PV, SHA, RJK, declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Since completion of this work, CB now works for Aztra Zeneca. Professor Ratko Djukanovic reports personal fees, has shares in the company and is a consultant to Synairgen, and personal fees from GlaxoSmithKline and Kymab, outside the submitted work.<br /> (© 2023 Naftel et al.)
Details
- Language :
- English
- ISSN :
- 1178-6965
- Volume :
- 16
- Database :
- MEDLINE
- Journal :
- Journal of asthma and allergy
- Publication Type :
- Academic Journal
- Accession number :
- 38144877
- Full Text :
- https://doi.org/10.2147/JAA.S430183